Skip to content
← Holders

Integral Health Asset Management, LLC

What Integral Health Asset Management, LLC reported holding on Form 13F for the quarter ended Sep 30, 2026.

CIK 1773206 · Filed Nov 16, 2026

Positions
97
Reported value
$1.6B
Opened
40
Closed
35
Other managers included
0

Values are as the managers reported them, in dollars.Open the Form 13F on SEC EDGAR

Quarters on file

  1. Sep 30, 2025$1.5B
    76 positions
  2. Dec 31, 2025$2B
    86 positions
  3. Mar 31, 2026$2.1B
    90 positions
  4. Jun 30, 2026$2.5B
    92 positions
  5. Sep 30, 2026$1.6B
    97 positions
SecuritySharesChangeValueOf portfolio
RVMDRevolution Medicines, Inc.
1M−33.3%$130.3M7.9%
INSMInsmed Inc
1.6M±0%$129M7.8%
EWTXEdgewise Therapeutics, Inc.
2.4M+20.0%$97.4M5.9%
CYTKCytokinetics Inc
1.6M±0%$72.5M4.4%
MRKMerck & Co., Inc.
450K+28.6%$65.4M4%
SRRKScholar Rock Holding Corp
1.3M+67.3%$60.6M3.7%
CNCCentene Corp
750K+150.0%$46.6M2.8%
AXSMAxsome Therapeutics, Inc.
250K−16.7%$46.1M2.8%
VERAVera Therapeutics, Inc.
1.5M−14.3%$32.3M2%
AMGNAmgen Inc
75KNew$31.6M1.9%
LFSTLifeStance Health Group, Inc.
2.6M−13.3%$31.3M1.9%
REGNRegeneron Pharmaceuticals, Inc.
40K±0%$30.3M1.8%
THCTenet Healthcare Corp
90K−45.5%$23M1.4%
BIIBBiogen Inc.
100K±0%$22.6M1.4%
TNGXTango Therapeutics, Inc.
1M±0%$22.5M1.4%
CAHCardinal Health Inc
100K−66.7%$22.3M1.4%
CVSCVS Health Corp
500K−54.5%$21.4M1.3%
NBIXNeurocrine Biosciences Inc
150K±0%$21.3M1.3%
VRTXVertex Pharmaceuticals Inc
40K±0%$20.9M1.3%
ORICOric Pharmaceuticals, Inc.
1.7M−10.5%$20.2M1.2%
BBIOBridgeBio Pharma, Inc.
300K+9.1%$19.7M1.2%
INCYIncyte Corp
160KNew$19.4M1.2%
DFTXDefinium Therapeutics, Inc.
500K−9.1%$19M1.2%
BTSGBrightSpring Health Services, Inc.
325K−40.9%$18.4M1.1%
ONCBeOne Medicines Ltd.
50KNew$18.3M1.1%
ROIVRoivant Sciences Ltd.
2M±0%$18.3M1.1%
LBRXLB Pharmaceuticals Inc
470K+213.3%$18M1.1%
BDXBecton Dickinson & Co
100KNew$17.9M1.1%
BSXBoston Scientific Corp
400K−55.6%$17.5M1.1%
EWEdwards Lifesciences Corp
200K−68.0%$17.3M1%
ERASErasca, Inc.
1.1M+13.0%$16.6M1%
ALKSAlkermes plc.
375K+275.0%$15.2M0.9%
MDTMedtronic plc
175K−12.5%$15.1M0.9%
GKOSGlaukos Corp
90K−40.0%$14.8M0.9%
EHCEncompass Health Corp
120KNew$14.6M0.9%
NVSNovartis AG
100K−50.0%$14.3M0.9%
ABSIAbsci Corp
1.3M+62.5%$14M0.8%
DGXQuest Diagnostics Inc
55K−72.5%$12.8M0.8%
ANROAlto Neuroscience, Inc.
500K±0%$12.8M0.8%
MDGLMadrigal Pharmaceuticals, Inc.
25K±0%$12.6M0.8%
BMYBristol Myers Squibb Co
200KNew$12.5M0.8%
EWTXEdgewise Therapeutics, Inc.Call option
300KNew$12.2M0.7%
QUREuniQure N.V.
500K−44.4%$12.1M0.7%
RYTMRhythm Pharmaceuticals, Inc.
250K−54.5%$11.9M0.7%
TEVATeva Pharmaceutical Industries Ltd
300KNew$11.9M0.7%
TVTXTravere Therapeutics, Inc.
200K−46.7%$11.8M0.7%
PRAXPraxis Precision Medicines, Inc.
40K±0%$11.6M0.7%
LIVANOVA PLCNOTE 2.500% 3/1
150KNew$11.5M0.7%
WATWaters Corp
25K−37.5%$11M0.7%
SRZNSurrozen, Inc.
325KNew$10.5M0.6%
INSPInspire Medical Systems, Inc.
150K+50.0%$10.4M0.6%
MLYSMineralys Therapeutics, Inc.
400K−11.1%$10.1M0.6%
TYRATyra Biosciences, Inc.
455KNew$10M0.6%
TMOThermo Fisher Scientific Inc.
14KNew$9.5M0.6%
RGNXRegenxbio Inc.
1.2M+50.0%$9M0.5%
SYRESpyre Therapeutics, Inc.
325K±0%$8.9M0.5%
OVIDOvid Therapeutics Inc.
3.5MNew$8.7M0.5%
COOCooper Companies, Inc.
150KNew$8.5M0.5%
CLYMClimb Bio, Inc.
700KNew$8M0.5%
ATTOAttovia Therapeutics, Inc.
450KNew$7.7M0.5%
ALNYAlnylam Pharmaceuticals, Inc.
30KNew$7.4M0.4%
FTHFaeth Therapeutics, Inc.
240KNew$7.1M0.4%
GHGuardant Health, Inc.
40KNew$7.1M0.4%
TGTXTG Therapeutics, Inc.
125KNew$7M0.4%
IONSIonis Pharmaceuticals Inc
150KNew$6.7M0.4%
VORVor Biopharma Inc.
350KNew$6.7M0.4%
COGTCogent Biosciences, Inc.
200K±0%$6.4M0.4%
TXG10x Genomics, Inc.
70KNew$6.3M0.4%
HELPHelus Pharma Inc.
500KNew$6.1M0.4%
IMTXImmatics N.V.
690KNew$6.1M0.4%
SANASana Biotechnology, Inc.
2M±0%$5.8M0.4%
CMPSCOMPASS Pathways plc
460KNew$5.7M0.3%
NGNENeurogene Inc.
200KNew$5.6M0.3%
ALMSAlumis Inc.
700K±0%$5.2M0.3%
ABVXAbivax S.A.
50KNew$5M0.3%
APMDApnimed, Inc.
225KNew$4.9M0.3%
BEAMBeam Therapeutics Inc.
200K−33.3%$4.9M0.3%
IVAInventiva S.A.
1.3M−14.5%$4.8M0.3%
CTNMContineum Therapeutics, Inc.
345KNew$4.6M0.3%
ELVNEnliven Therapeutics, Inc.
100K−33.3%$4.6M0.3%
BHVNBiohaven Ltd.
300K−57.1%$4M0.2%
IDYAIDEAYA Biosciences, Inc.
100K±0%$3.8M0.2%
TARAProtara Therapeutics, Inc.
1.3M−16.7%$3.8M0.2%
NRIXNurix Therapeutics, Inc.
160KNew$3.8M0.2%
GLUEMonte Rosa Therapeutics, Inc.
300KNew$3.6M0.2%
KARDKardigan, Inc.
225K+12.5%$3.3M0.2%
SVRASavara Inc
600K±0%$3.1M0.2%
CAICaris Life Sciences, Inc.
100KNew$3.1M0.2%
TRVITrevi Therapeutics, Inc.
200K±0%$2.9M0.2%
IKTInhibikase Therapeutics, Inc.
1.4M±0%$2.8M0.2%
MAZEMaze Therapeutics, Inc.
100KNew$2.7M0.2%
AGMBAgomAb Therapeutics NV
235KNew$2.6M0.2%
ETRAElectra Therapeutics, Inc.
200KNew$2.3M0.1%
BRVEBraveheart Bio, Inc.
100KNew$2M0.1%
CAMPCamp4 Therapeutics Corp
495KNew$2M0.1%
ACRSAclaris Therapeutics, Inc.
200KNew$1.1M0.1%
XFORX4 Pharmaceuticals, Inc
250KNew$725K0.1%